Khan Bilal, Chong Insun, Ostrom Quinn, Ahmed Sara, Dandachi Dima, Kotrotsou Aikaterini, Colen Rivka, Morón Fanny
Department of Radiology, Baylor College of Medicine, Houston, TX, USA.
Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Oncotarget. 2020 Nov 10;11(45):4093-4103. doi: 10.18632/oncotarget.27800.
Ki-67 expression, a marker of tumor proliferation, is considered a prognostic factor in primary CNS lymphoma (PCNSL). Apparent diffusion coefficient (ADC) parameters have also been proposed as imaging biomarkers for tumor progression and proliferative activity in various malignancies. The aim of this study is to investigate the correlation between ADC parameters, Ki-67 expression, overall survival (OS) and progression free survival (PFS) in PCNSL.
Patients diagnosed with PCNSL at MD Anderson Cancer Center between Mar 2000 and Jul 2016 and at Ben Taub Hospital between Jan 2012 and Dec 2016 were retrospectively studied. Co-registered ADC maps and post-contrast images underwent whole tumor segmentation. Normalized ADC parameters (nADC) were calculated as the ratio to normal white matter. Percentiles of nADC were calculated and were correlated with Ki-67 using Pearson's correlation coefficient and clinical outcomes (OS and PFS) using Cox proportional hazards models.
Selection criteria yielded 90 patients, 23 patients living with HIV (PLWH) and 67 immunocompetent patients. Above median values for nADC, nADC, nADC and nADC were associated with improved OS in all patients ( < 0.05). Above median values for nADC, nADC, nADC, nADC and kurtosis were associated with improved PFS in all patients ( < 0.05). In patients with available Ki-67 expression data ( = 22), nADC, nADC and nADC inversely correlated with Ki-67 expression ( < 0.05). For PLWH, there was no correlation between ADC parameters and Ki-67 expression or clinical outcomes.
ADC histogram analysis can predict tumor proliferation and survival in immunocompetent patients with PCNSL, but with limited utility in PLWH.
Ki-67表达作为肿瘤增殖的标志物,被认为是原发性中枢神经系统淋巴瘤(PCNSL)的一个预后因素。表观扩散系数(ADC)参数也已被提议作为各种恶性肿瘤中肿瘤进展和增殖活性的影像生物标志物。本研究的目的是探讨PCNSL中ADC参数、Ki-67表达、总生存期(OS)和无进展生存期(PFS)之间的相关性。
回顾性研究2000年3月至2016年7月在MD安德森癌症中心以及2012年1月至2016年12月在本陶布医院诊断为PCNSL的患者。对配准的ADC图和增强后图像进行全肿瘤分割。将标准化ADC参数(nADC)计算为与正常白质的比值。计算nADC的百分位数,并使用Pearson相关系数将其与Ki-67相关联,使用Cox比例风险模型将其与临床结局(OS和PFS)相关联。
选择标准产生了90例患者,其中23例为HIV感染者(PLWH),67例为免疫功能正常患者。nADC、nADC、nADC和nADC高于中位数与所有患者的OS改善相关(<0.05)。nADC、nADC、nADC、nADC和峰度高于中位数与所有患者的PFS改善相关(<0.05)。在有可用Ki-67表达数据的患者(=22)中,nADC、nADC和nADC与Ki-67表达呈负相关(<0.05)。对于PLWH,ADC参数与Ki-67表达或临床结局之间无相关性。
ADC直方图分析可预测免疫功能正常的PCNSL患者的肿瘤增殖和生存,但在PLWH中的效用有限。